<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-220-12-27-35</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2648</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МИКРОБИОТА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MICROBIOTA</subject></subj-group></article-categories><title-group><article-title>Коинфекция Helicobacter pylori и герпесвирусами при хроническом гастрите</article-title><trans-title-group xml:lang="en"><trans-title>Helicobacter pylori and herpes viruses co-infection in chronic gastritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8282-3056</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лузина</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Luzina</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">el.luz@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9498-9216</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ларева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lareva</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8736-5851</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лазебник</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazebnik</surname><given-names>L. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8285-6061</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дутова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dutova</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4164-1555</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чарторижская</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chartorizhskaya</surname><given-names>N. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-0908-2550</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муцольгова</surname><given-names>Т. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Mutsolgova</surname><given-names>T. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования Читинская государственная медицинская академия Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Московский государственный медико-стоматологический университет им. А. И. Евдокимова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A. I. Yevdokimov Moscow State University of Medicine and Dentistry</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Многопрофильный медицинский центр «Медлюкс»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>MEDLUX multidisciplinary medical center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>18</day><month>12</month><year>2023</year></pub-date><volume>0</volume><issue>12</issue><fpage>27</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лузина Е.В., Ларева Н.В., Лазебник Л.Б., Дутова А.А., Чарторижская Н.Н., Муцольгова Т.Б., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Лузина Е.В., Ларева Н.В., Лазебник Л.Б., Дутова А.А., Чарторижская Н.Н., Муцольгова Т.Б.</copyright-holder><copyright-holder xml:lang="en">Luzina E.V., Lareva N.V., Lazebnik L.B., Dutova A.A., Chartorizhskaya N.N., Mutsolgova T.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2648">https://www.nogr.org/jour/article/view/2648</self-uri><abstract><p>Helicobacter pylori (НР) является доказанным патогеном для желудка. Наряду с НР, колонизировать слизистую оболочку желудка (СОЖ) могут другие инфекционные агенты, в частности, герпесвирусы. Было проведено исследование, в ходе которого изучалась частота встречаемости и ассоциация НР и вирусов Эпштейна-Барр (ВЭБ), цитомегаловируса (ЦМВ) и герпесвируса 6 типа (ГВ6), роль этих патогенов в формировании воспалительных и дистрофических изменений в желудке, а также влияние вирусов на эффективность эрадикации НР. Материалы и методы. Обследовано 99 человек, у которых в биопсийных образцах из антрального отдела желудка определялась ДНК НР и вирусов (ВЭБ, ЦМВ, ГВ6) методом полимеразной цепной реакции. Морфологическое исследование СОЖ по системе OLGA выполнено у 56 человек. Эрадикационное лечение НР провели 29 человек, у 9 из которых определялись ДНК вирусов. Статистическая обработка проведена методом описательной статистики, t-критерия Стьюдента и х2 (программное обеспечение Биостатистика). Результаты. ДНК НР в СОЖ была обнаружена в 44,4%, ДНК герпесвирусов в 35,3% случаев. Наиболее часто определялся ВЭБ - у 21 пациента, ГВ6 - у 11 человек, в 3 образцах обнаружены оба вируса (ВЭБ + ГВ6). ДНК ЦМВ не найдена. Коинфекция НР и герпесвирусов определялась в 2 раза чаще, чем при отсутствии бактерии (50% и 23,6% соответственно, р=0,007). Чаще регистрировалось сочетание НР и ВЭБ (36,4%), моноинфекция ВЭБ встречалась в 9,1% (р&lt;0,001). ГВ6 в 14,5% определялся в отсутствии НР, в комбинации с НР - в 6,8% случаев (р=0,225). При морфологическом исследовании биоптатов желудка по системе OLGA III-IV степень активности воспаления имела место у 74% пациентов при обнаружении НР и у 31% - в отсутствии бактерии (р=0,002). Средняя степень активности воспаления составила 2,14±0,20 балла у интактных по какой-либо инфекции пациентов, увеличивалась на 1 балл при наличии НР (р&lt;0,01) и не изменялась при персистенции вирусов (р=0,235). Не было зарегистрировано различий между выраженностью атрофических изменений при обнаружении НР или вирусов (р&gt;0,05). Успешная эрадикация НР зарегистрирована в 75% случаев в отсутствии вирусной инфекции и в 11,1% - при коинфекции с герпесвирусами (р=0,002). Заключение. Колонизация СОЖ характерна для НР, ВЭБ и ГВ6. Наиболее часто регистрировалась комбинация ВЭБ и НР. Высокая степень активности воспаления характерна для хеликобактерной инфекции. При неэффективной эрадикации НР необходимо оценивать наличие герпесвирусов в СОЖ, которые могут препятствовать успеху лечения.</p></abstract><trans-abstract xml:lang="en"><p>Helicobacter pylori (HP) is a proven pathogen of the stomach. Along with HP, other infectious agents, in particular herpesviruses, can colonize the gastric mucosa (GM). The occurrence and association of HP and Epstein-Barr viruses (EBV), cytomegalovirus (CMV) and herpesvirus type 6 (HV6), the effect of these pathogens on inflammation, atrophy in the stomach, on the effectiveness of HP eradication were studied. Materials and methods. DNA of HP and viruses (EBV, CMV, HV6) was determined by polymerase chain reaction in biopsy samples of the antrum of the stomach of 99 people. Morphological study of GM according to the OLGA system was performed in 56 patients. HP eradication treatment was carried out in 29 people, in 9 of whom DNA of viruses was found. Descriptive statistics, Student’s t-test and x2-test were used (Biostatistics program). Results. HP DNA in GM was found in 44.4%, herpes virus DNA in 35.3% of cases. EBV was detected more often - in 21 patients, HV6 - in 11 people, both viruses (EBV + HV6) were found in 3 samples. CMV DNA was not found. HP co-infection with herpesviruses was determined 2 times more often than in the absence of bacteria (50% and 23.6%, respectively, p=0.007). A combination of HP and EBV was more often recorded (36.4%), EBV mono-infection occurred in 9.1% (p&lt;0.001). HB6 in 14.5% was determined in the absence of HP, in combination with HP - in 6.8% of cases (p = 0.225). The morphology of gastric biopsies showed that III-IV degree of inflammation according to OLGA occurred in 74% of patients with HP and in 31% in the absence of bacteria (p=0.002). The average degree of inflammation was 2.14±0.20 points in patients intact for any infection, increased by 1 point with НР (p&lt;0.01) and did not change with the persistence of viruses (p=0.235). There were no differences between atrophic changes when HP or viruses were detected (p&gt;0.05). Successful HP eradication was registered in 75% of cases in the absence of a viral infection and in 11.1% of cases with co-infection with herpes viruses (p=0.002). Conclusion. Colonization of the GM is typical for HP, EBV and HV6. Combination of EBV and HP was the most common. A high degree of inflammation activity is characteristic of Helicobacter pylori infection. In case of non-effective eradication of HP, it is necessary to examine herpes viruses, which may interfere with the success of treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гастрит</kwd><kwd>Helicobacter pylori</kwd><kwd>вирус Эпштейна-Барр</kwd><kwd>цитомегаловирус</kwd><kwd>герпесвирус 6 типа</kwd><kwd>коинфекция</kwd><kwd>эрадикация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gastritis</kwd><kwd>Helicobacter pylori</kwd><kwd>Epstein-Barr virus</kwd><kwd>cytomegalovirus</kwd><kwd>herpesvirus type 6</kwd><kwd>coinfection</kwd><kwd>eradication</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Malfertheiner P., Megraud F., Rokkas T., Gisbert J. P., Liou J. M., Schulz C., Gasbarrini A., Hunt R. H., Leja M., O’Morain C., Rugge M., Suerbaum S., Tilg H., Sugano K., El-Omar E.M.; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8: gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745.</mixed-citation><mixed-citation xml:lang="en">Malfertheiner P., Megraud F., Rokkas T., Gisbert J. P., Liou J. M., Schulz C., Gasbarrini A., Hunt R. H., Leja M., O’Morain C., Rugge M., Suerbaum S., Tilg H., Sugano K., El-Omar E.M.; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8: gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bordin D.S., Livzan M. A., Osipenko M. F., Mozgovoy S. I., Andreyev D. N., Maev I. V. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology. 2022;(9):5-21. (In Russ.) doi: 10.31146/1682-8658-ecg-205-9-5-21.@@ Бордин Д. С., Ливзан М. А., Осипенко М. Ф., Мозговой С. И., Андреев Д. Н., Маев И. В. Ключевые положения консенсуса Маастрихт VI. Экспериментальная и клиническая гастроэнтерология. 2022;(9):5-21. doi:10.31146/1682-8658-ecg-205-9-5-21.</mixed-citation><mixed-citation xml:lang="en">Bordin D.S., Livzan M. A., Osipenko M. F., Mozgovoy S. I., Andreyev D. N., Maev I. V. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology. 2022;(9):5-21. (In Russ.) doi: 10.31146/1682-8658-ecg-205-9-5-21.@@ Бордин Д. С., Ливзан М. А., Осипенко М. Ф., Мозговой С. И., Андреев Д. Н., Маев И. В. Ключевые положения консенсуса Маастрихт VI. Экспериментальная и клиническая гастроэнтерология. 2022;(9):5-21. doi:10.31146/1682-8658-ecg-205-9-5-21.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Livzan M.A., Mozgovoy S. I., Kononov A. V. Gastritis after eradication of Helicobacter pylori - simple traces or serious consequences? Lechaschi Vrach. 2011; 7: 7. (In Russ.)@@ Ливзан М. А., Мозговой С. И., Кононов А. В. Гастрит после эрадикации Helicobacter pylori - простые следы или серьезные последствия? Лечащий врач. 2011;7:7.</mixed-citation><mixed-citation xml:lang="en">Livzan M.A., Mozgovoy S. I., Kononov A. V. Gastritis after eradication of Helicobacter pylori - simple traces or serious consequences? Lechaschi Vrach. 2011; 7: 7. (In Russ.)@@ Ливзан М. А., Мозговой С. И., Кононов А. В. Гастрит после эрадикации Helicobacter pylori - простые следы или серьезные последствия? Лечащий врач. 2011;7:7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung K.S., Leung W. K. Risk of gastric cancer development after eradication of Helicobacter pylori. World J Gastrointest Oncol. 2018 May 15;10(5):115-123. doi: 10.4251/wjgo.v10.i5.115.</mixed-citation><mixed-citation xml:lang="en">Cheung K.S., Leung W. K. Risk of gastric cancer development after eradication of Helicobacter pylori. World J Gastrointest Oncol. 2018 May 15;10(5):115-123. doi: 10.4251/wjgo.v10.i5.115.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Isakov V. A., Arhipova E. I., Isakov D. V. [Herpesviral infections in human (2nd edition, re-vised and enlarged): Guidelines for physicians]. Saint-Petersburg. SpecLit, 2013. 670 pp. (In Russ.)@@ Исаков В. А., Архипова Е. И., Исаков Д. В. Герпеcвирусные инфекции че-ловека: руководство для врачей /под ред. В. А. Исакова. - СПб.: СпецЛит, 2013. - 2-е изд., перераб. и доп. - 670 с.</mixed-citation><mixed-citation xml:lang="en">Isakov V. A., Arhipova E. I., Isakov D. V. [Herpesviral infections in human (2nd edition, re-vised and enlarged): Guidelines for physicians]. Saint-Petersburg. SpecLit, 2013. 670 pp. (In Russ.)@@ Исаков В. А., Архипова Е. И., Исаков Д. В. Герпеcвирусные инфекции че-ловека: руководство для врачей /под ред. В. А. Исакова. - СПб.: СпецЛит, 2013. - 2-е изд., перераб. и доп. - 670 с.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sarshari B., Mohebbi S. R., Ravanshad M., Shahrokh S., Aghdaei H. A., Zali M. R. Detection and quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus-6 in stomach frozen tissue of chronic gastritis and gastric cancer patients. Microbiol Immunol. 2022 Aug;66(8):379-385. doi: 10.1111/1348-0421.13013.</mixed-citation><mixed-citation xml:lang="en">Sarshari B., Mohebbi S. R., Ravanshad M., Shahrokh S., Aghdaei H. A., Zali M. R. Detection and quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus-6 in stomach frozen tissue of chronic gastritis and gastric cancer patients. Microbiol Immunol. 2022 Aug;66(8):379-385. doi: 10.1111/1348-0421.13013.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wallaschek N., Reuter S., Silkenat S., Wolf K. et al. Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids. PLoS Pathog. 2021 Feb 17;17(2): e1009210. doi: 10.1371/journal.ppat.1009210.</mixed-citation><mixed-citation xml:lang="en">Wallaschek N., Reuter S., Silkenat S., Wolf K. et al. Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids. PLoS Pathog. 2021 Feb 17;17(2): e1009210. doi: 10.1371/journal.ppat.1009210.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Spivak E.M., Khavkin A. I. Epstein-Barr virus in chronic gastroduodenal pathology in children (literature review). Farmateka. 2022; 29(2): 25-29. (in Russ.) doi: 10.18565/pharmateca.2022.2.25-29.@@ Спивак Е. М., Хавкин А. И. Вирус Эпштейна-Барр при хронической гастродуоденальной патологии у детей (обзор литературы). Фарматека. 2022; 29(2): 25-29. doi: 10.18565/pharmateca.2022.2.25-29.</mixed-citation><mixed-citation xml:lang="en">Spivak E.M., Khavkin A. I. Epstein-Barr virus in chronic gastroduodenal pathology in children (literature review). Farmateka. 2022; 29(2): 25-29. (in Russ.) doi: 10.18565/pharmateca.2022.2.25-29.@@ Спивак Е. М., Хавкин А. И. Вирус Эпштейна-Барр при хронической гастродуоденальной патологии у детей (обзор литературы). Фарматека. 2022; 29(2): 25-29. doi: 10.18565/pharmateca.2022.2.25-29.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Krulevskiĭ V.A., Petrovskiĭ A. N., Anichkov N. M., Novikova V. P. Chronic gastritis and herpetic infections in subjects of different ages. Arkh Patol. 2010 Jan-Feb;72(1):33-35. (in Russ.)@@ Крулевский В. А., Петровский А. Н., Аничков Н. М., Новикова В. П. Хронический гастрит и герпетические инфекции у лиц разного возраста. Архив патологии. 2010; 72(1): 33-35.</mixed-citation><mixed-citation xml:lang="en">Krulevskiĭ V.A., Petrovskiĭ A. N., Anichkov N. M., Novikova V. P. Chronic gastritis and herpetic infections in subjects of different ages. Arkh Patol. 2010 Jan-Feb;72(1):33-35. (in Russ.)@@ Крулевский В. А., Петровский А. Н., Аничков Н. М., Новикова В. П. Хронический гастрит и герпетические инфекции у лиц разного возраста. Архив патологии. 2010; 72(1): 33-35.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Moral-Hernández O.D., Castañón-Sánchez C.A., Reyes-Navarrete S. et al. Multiple infections by EBV, HCMV and Helicobacter pylori are highly frequent in patients with chronic gastritis and gastric cancer from Southwest Mexico: An observational study. Medicine (Baltimore). 2019 Jan; 98(3): e14124. doi: 10.1097/MD.0000000000014124.</mixed-citation><mixed-citation xml:lang="en">Moral-Hernández O.D., Castañón-Sánchez C.A., Reyes-Navarrete S. et al. Multiple infections by EBV, HCMV and Helicobacter pylori are highly frequent in patients with chronic gastritis and gastric cancer from Southwest Mexico: An observational study. Medicine (Baltimore). 2019 Jan; 98(3): e14124. doi: 10.1097/MD.0000000000014124.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gareayaghi N., Akkus S., Saribas S. et al. Epstein-Barr Virus and Helicobacter pylori co-infection in patients with gastric cancer and duodenale ulcer. New Microbiol. 2021 Oct;44(4):217-226.</mixed-citation><mixed-citation xml:lang="en">Gareayaghi N., Akkus S., Saribas S. et al. Epstein-Barr Virus and Helicobacter pylori co-infection in patients with gastric cancer and duodenale ulcer. New Microbiol. 2021 Oct;44(4):217-226.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dávila-Collado R., Jarquín-Durán O., Dong L. Th., Espinoza J. L. Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders. Pathogens. 2020 Feb 6; 9(2): 104. doi: 10.3390/pathogens9020104.</mixed-citation><mixed-citation xml:lang="en">Dávila-Collado R., Jarquín-Durán O., Dong L. Th., Espinoza J. L. Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders. Pathogens. 2020 Feb 6; 9(2): 104. doi: 10.3390/pathogens9020104.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fekadu, S., Kanehiro, Y., Kartika, A.V. et al. Gastric epithelial attachment of Helicobacter pylori induces EphA2 and NMHC-IIA receptors for Epstein-Barr virus. Cancer Sci. 2021 Nov;112(11):4799-4811. doi: 10.1111/cas.15121.</mixed-citation><mixed-citation xml:lang="en">Fekadu, S., Kanehiro, Y., Kartika, A.V. et al. Gastric epithelial attachment of Helicobacter pylori induces EphA2 and NMHC-IIA receptors for Epstein-Barr virus. Cancer Sci. 2021 Nov;112(11):4799-4811. doi: 10.1111/cas.15121.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fukuda M., Ikuta K., Yanagihara K., Tajima M., Kuratsune H., Kurata T., Sairenji T. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. Virology. 2001 Sep 15;288(1):109-18. doi: 10.1006/viro.2001.1071.</mixed-citation><mixed-citation xml:lang="en">Fukuda M., Ikuta K., Yanagihara K., Tajima M., Kuratsune H., Kurata T., Sairenji T. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. Virology. 2001 Sep 15;288(1):109-18. doi: 10.1006/viro.2001.1071.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Minoura-Etoh, J., Gotoh, K., Sato, R. et al. Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol. 2006 Jul;55(Pt 7):905-911. doi: 10.1099/jmm.0.46580-0.</mixed-citation><mixed-citation xml:lang="en">Minoura-Etoh, J., Gotoh, K., Sato, R. et al. Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol. 2006 Jul;55(Pt 7):905-911. doi: 10.1099/jmm.0.46580-0.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Saju P., Murata-Kamiya N., Hayashi T. et al. Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Nat Microbiol. 2016 Mar 14;1:16026. doi: 10.1038/nmicrobiol.2016.26.</mixed-citation><mixed-citation xml:lang="en">Saju P., Murata-Kamiya N., Hayashi T. et al. Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Nat Microbiol. 2016 Mar 14;1:16026. doi: 10.1038/nmicrobiol.2016.26.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kato I., Zhang J., Sun J. Bacterial-Viral Interactions in Human Orodigestive and Female Genital Tract Cancers: A Summary of Epidemiologic and Laboratory Evidence. Cancers (Basel). 2022 Jan; 14(2): 425. doi: 10.3390/cancers14020425.</mixed-citation><mixed-citation xml:lang="en">Kato I., Zhang J., Sun J. Bacterial-Viral Interactions in Human Orodigestive and Female Genital Tract Cancers: A Summary of Epidemiologic and Laboratory Evidence. Cancers (Basel). 2022 Jan; 14(2): 425. doi: 10.3390/cancers14020425.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Usui G., Matsusaka K., Mano Ya. et al. DNA Methylation and Genetic Aberrations in Gastric Cancer. Digestion. 2021;102(1):25-32. doi: 10.1159/000511243.</mixed-citation><mixed-citation xml:lang="en">Usui G., Matsusaka K., Mano Ya. et al. DNA Methylation and Genetic Aberrations in Gastric Cancer. Digestion. 2021;102(1):25-32. doi: 10.1159/000511243.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Dursun N., Hacıhasanoğlu E., Okçu O., Paşaoğlu E., Leblebici C. Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection. Turk J Gastroenterol. 2020 Mar;31(3):205-210. doi: 10.5152/tjg.2020.18850.</mixed-citation><mixed-citation xml:lang="en">Dursun N., Hacıhasanoğlu E., Okçu O., Paşaoğlu E., Leblebici C. Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection. Turk J Gastroenterol. 2020 Mar;31(3):205-210. doi: 10.5152/tjg.2020.18850.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao K., Zhang Yu, Xia S. et al. Epstein-Barr Virus is Associated with Gastric Cancer Precursor: Atrophic Gastritis.Int J Med Sci. 2022 May 21;19(5):924-931. doi: 10.7150/ijms.71820.</mixed-citation><mixed-citation xml:lang="en">Zhao K., Zhang Yu, Xia S. et al. Epstein-Barr Virus is Associated with Gastric Cancer Precursor: Atrophic Gastritis.Int J Med Sci. 2022 May 21;19(5):924-931. doi: 10.7150/ijms.71820.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cárdenas-Mondragón M.G., Carreón-Talavera R., Camorlinga-Ponce M. et al. Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients. PLoS One. 2013 Apr 24; 8(4): e62850. doi: 10.1371/journal.pone.0062850.</mixed-citation><mixed-citation xml:lang="en">Cárdenas-Mondragón M.G., Carreón-Talavera R., Camorlinga-Ponce M. et al. Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients. PLoS One. 2013 Apr 24; 8(4): e62850. doi: 10.1371/journal.pone.0062850.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Volynets G.V., Khavkin A. I., Nikonov Ye.L., Murashkin V. Yu. Specificities of morphological changes in gastric mucosa in children depending on Helicobacter pylori and Epstein-Barr virus infections. Voprosy detskoj dietologii. 2018; 16(4):5-12. (in Russ.) doi: 10.20953/1727-5784-2018-4-5-12.@@ Волынец Г. В., Хавкин А. И., Никонов Е. Л., Мурашкин В. Ю. Особенности морфологических изменений слизистой оболочки желудка у детей в зависимости от инфекции Helicobacter pylori и Эпштейна-Барр-вирусной инфекции. Вопросы детской диетологии. 2018; 16(4):5-12. doi: 10.20953/1727-5784-2018-4-5-12.</mixed-citation><mixed-citation xml:lang="en">Volynets G.V., Khavkin A. I., Nikonov Ye.L., Murashkin V. Yu. Specificities of morphological changes in gastric mucosa in children depending on Helicobacter pylori and Epstein-Barr virus infections. Voprosy detskoj dietologii. 2018; 16(4):5-12. (in Russ.) doi: 10.20953/1727-5784-2018-4-5-12.@@ Волынец Г. В., Хавкин А. И., Никонов Е. Л., Мурашкин В. Ю. Особенности морфологических изменений слизистой оболочки желудка у детей в зависимости от инфекции Helicobacter pylori и Эпштейна-Барр-вирусной инфекции. Вопросы детской диетологии. 2018; 16(4):5-12. doi: 10.20953/1727-5784-2018-4-5-12.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Akkuratova I.S., Spivak E. M., Manyakina O. M. Coinfection of gastric mucosa with Helicobacter Pylori and Epstein-Barr virus as a factor of ineffectiveness of antihelicobacter chronic gastritis therapy in adolescents. Perm Medical Journal. 2019; 36(1): 27-30. (in Russ.) doi: 10.17816/pmj36127-30.@@ Аккуратова И. С., Спивак Е. М., Манякина О. М. Коинфицирование слизистой оболочки желудка Helicobacter Pylori и вирусом Эпштейна - Барр как фактор неэффективности антихеликобактерной терапии хронического гастрита у подростков. Пермский медицинский журнал. 2019; 36(1): 27-30. doi: 10.17816/pmj36127-30.</mixed-citation><mixed-citation xml:lang="en">Akkuratova I.S., Spivak E. M., Manyakina O. M. Coinfection of gastric mucosa with Helicobacter Pylori and Epstein-Barr virus as a factor of ineffectiveness of antihelicobacter chronic gastritis therapy in adolescents. Perm Medical Journal. 2019; 36(1): 27-30. (in Russ.) doi: 10.17816/pmj36127-30.@@ Аккуратова И. С., Спивак Е. М., Манякина О. М. Коинфицирование слизистой оболочки желудка Helicobacter Pylori и вирусом Эпштейна - Барр как фактор неэффективности антихеликобактерной терапии хронического гастрита у подростков. Пермский медицинский журнал. 2019; 36(1): 27-30. doi: 10.17816/pmj36127-30.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Golubkina E.V., Kamneva N. V., Umerova A. R. Role of the CagA gene in diagnostics of Helicobacter pylori associated diseases of stomach and duodenum. Astrakhan Medical Journal. 2017; 12(2): 8-14. (in Russ.)@@ Голубкина Е. В., Камнева Н. В., Умерова А. Р. Роль CagA гена в диагностике ассоциированных с Helicobacter pylori заболеваний желудка и двенадцатиперстной кишки. Астраханский медицинский журнал. 2017; 12(2): 8-14.</mixed-citation><mixed-citation xml:lang="en">Golubkina E.V., Kamneva N. V., Umerova A. R. Role of the CagA gene in diagnostics of Helicobacter pylori associated diseases of stomach and duodenum. Astrakhan Medical Journal. 2017; 12(2): 8-14. (in Russ.)@@ Голубкина Е. В., Камнева Н. В., Умерова А. Р. Роль CagA гена в диагностике ассоциированных с Helicobacter pylori заболеваний желудка и двенадцатиперстной кишки. Астраханский медицинский журнал. 2017; 12(2): 8-14.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rahal E.A., Hajjar H., Rajeh M. et al. Epstein-Barr Virus and Hu-man herpes virus 6 Type A DNA Enhance IL-17 Production in Mice. Viral Immunol. 2015 Jun;28(5):297-302. doi: 10.1089/vim.2014.0129.</mixed-citation><mixed-citation xml:lang="en">Rahal E.A., Hajjar H., Rajeh M. et al. Epstein-Barr Virus and Hu-man herpes virus 6 Type A DNA Enhance IL-17 Production in Mice. Viral Immunol. 2015 Jun;28(5):297-302. doi: 10.1089/vim.2014.0129.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Afanasenkova T. E., Dubskaya E. E. The role of cycloferon in the treatment of chronic Helicobacter pylori-induced gastritis with gastric erosions associated with Epstein - Barr virus. Lechaschi Vrach. 2022; 2 (25): 13-19. (in Russ.) doi: 10.51793/OS.2022.25.2.002.@@ Афанасенкова Т. Е., Дубская Е. Е. Лечение хронического Helicobacter pylori-индуцированного гастрита с эрозиями желудка, ассоциированного с вирусом Эпштейна-Барр. Лечащий врач. 2022; 25(2): 13-19. doi: 10.51793/OS.2022.25.2.002.</mixed-citation><mixed-citation xml:lang="en">Afanasenkova T. E., Dubskaya E. E. The role of cycloferon in the treatment of chronic Helicobacter pylori-induced gastritis with gastric erosions associated with Epstein - Barr virus. Lechaschi Vrach. 2022; 2 (25): 13-19. (in Russ.) doi: 10.51793/OS.2022.25.2.002.@@ Афанасенкова Т. Е., Дубская Е. Е. Лечение хронического Helicobacter pylori-индуцированного гастрита с эрозиями желудка, ассоциированного с вирусом Эпштейна-Барр. Лечащий врач. 2022; 25(2): 13-19. doi: 10.51793/OS.2022.25.2.002.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Saxena A., Prasad K. N., Ghoshal U. Ch. at al. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease. Scand J Gastroenterol. 2008;43(6):669-74. doi: 10.1080/00365520801909660.</mixed-citation><mixed-citation xml:lang="en">Saxena A., Prasad K. N., Ghoshal U. Ch. at al. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease. Scand J Gastroenterol. 2008;43(6):669-74. doi: 10.1080/00365520801909660.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Jha H.C., Pei Yo., Robertson E. S. Epstein-Barr Virus: Diseases Linked to Infection and Transformation. Front Microbiol. 2016; 7: 1602. doi: 10.3389/fmicb.2016.01602.</mixed-citation><mixed-citation xml:lang="en">Jha H.C., Pei Yo., Robertson E. S. Epstein-Barr Virus: Diseases Linked to Infection and Transformation. Front Microbiol. 2016; 7: 1602. doi: 10.3389/fmicb.2016.01602.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lahner E., Carabotti M., Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J Gastroenterol. 2018 Jun 14;24(22):2373-2380. doi: 10.3748/wjg.v24.i22.2373</mixed-citation><mixed-citation xml:lang="en">Lahner E., Carabotti M., Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J Gastroenterol. 2018 Jun 14;24(22):2373-2380. doi: 10.3748/wjg.v24.i22.2373</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
